For thirty years, Biomed has developed innovative in-vitro diagnostic tools for clinicians around the globe. With new threats emerging in the form of HAIs – as well as the potential resurgence of AMR pathogens, our team stands ready to assist in your efforts to make the world a safer, healthier place.
Heathcare associated infections (HAIs), specifically hospital acquired nosociomal infections, pose a real threat to patient safety. Biomed's InTray can play a critical role with infection control, helping to substantially detect HAI prevalence and reduce associated costs.
Antimicrobial resistance (AMR) is a growing global public health threat. BioMed’s InTray® products are uniquely designed to sample collect, transport, and detect in one device, streamlining your diagnostic workflow.